Kaleidoscope of Healthcare will present different facets of a variety of elements of healthcare. The three drivers of this ever
changing panorama: ?Jugaad? ? a bane and boon, ?Big Pharma Big Troubles? and the ?Healthcare on the Horizon?. Jugaad
essentially means ?frugal innovation?? any kind of creative thinking that maximizes the value of resources and outcome. Jugaad
also has immense possibilities of getting misunderstood ? get misdirected and misused to show impossible performances. It
may work for a while but eventually, spells disaster. FDA is trying to make an example of companies that are trying to push
the envelope. With the Emerging Markets (EM) becoming more important, the FDA oversight is also expected to change.
Big pharma is facing big troubles. Over 70% of the NCEs don?t recover their cost of discovery. How are they attempting to
overcome the most unusual challenges in their history? ??Amputating? themselves to ?improve prognosis?? ? The EM?. ?FDA
management? is on the top of the list of the three Key Success Factors. Healthcare on the horizon points to a future totally divorced
from where we stand today? entirely new paradigm? Several outstanding discoveries lab grown organs, spray- on-skin to heal
without scarring? many more ?
The presentation will end with an attempt to prognosticate the future? and a whole lot of 'food for thought'
Devinder Pal obtained a Master Degree in Pharmacy from the prestigious Banaras Hindu University (standing first in the University) and ?AMP from
AIM-Manila?. Starting as the youngest Production Manager for a leading European group Roussel Uclaf ? now Aventis, he rose to be the Whole
-time Director. After 13 years of rich and varied experience, he moved on to Parke Davis- Warner Lambert as Vice President & Whole-time Director,
responsible for the entire Technical operations, including Quality, R&D, Projects, Logistics ? the whole lot ? for the next 22 years. Following this he
served as Joint Managing Director of Elder Pharmaceuticals. As the founder President & CEO of Catalyst Pharma Consulting for the last 14 years,
he is a much sought after Consultant to leading names of Indian and MNCs, as also companies based in the middle east, UK, Europe, Canada,
USA, and elsewhere in the world. His focus areas include gap analysis, due diligence, orienting the focus of business, diversification designing
and upgrading plants, Cost reduction and efficiency improvement etc. www.CatalystPharmaConsult.com has more. Devinder has served on many
national and international forums including the Expert Committee of the USP; Member Indian Pharmacopoeia Committee & Chairman non-parental
produts; Drug Technical Advisory Board; Governing Body- Bombay College of Pharmacy; Indian Institute of Packaging; Pharma Pulse; Pharma
Biz; Pharma Manager; Pharma Business & Technology; OPPI; PAMDAL; and IDM, etc. Fellow and Life Member, he was the President of the
Indian Pharmaceutical Association; National President of the Indian Pharmaceutical Congress, and the Vice President of the UK based prestigious
Commonwealth Pharmaceutical Association, etc. and serves with distinction on the elite selection committees, for Lifetime Achievement, Eminent
Pharmacist, Fellowship Awards, etc. Thus over the last 5 decades, he has intimately observed from ?coming into being? to ?coming of age? of Pharma
Industry in India, and has, not only participated but, has made notable contribution to the growth of Industry and the Profession. His intuitive,
perceptive, analytical and creative approach combined with astute and inspiring leadership is envy of many. No wonder, many who are at the helm
of affairs today, attribute their success to him and unabashedly and gratefully acknowledge his role of a ?guru?, while he sees himself as a ?chela?. Mr
Devinder Pal is recipient of several prestigious awards, which include, ?Distinguished Alumnus Award?, ?Pharma Excellence Professional Award?; the
?Eminent Pharmacist Award?; ?Lifetime Achievement Award?, Khorana Memorial Award among others. He has been covered in ?Who?s Who in the World?.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals